---
layout: post
title: "Excise Tax on Designated Drugs; Procedural Requirements"
date: 2026-02-05 18:57:04 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-21586
original_published: 2023-10-02 00:00:00 +0000
significance: 8.00
---

# Excise Tax on Designated Drugs; Procedural Requirements

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** October 02, 2023 00:00 UTC
**Document Number:** 2023-21586

## Summary

This document contains proposed regulations that would provide guidance on how taxpayers will report liability for the excise tax imposed on manufacturers, producers, or importers of certain designated drugs. The proposed regulations affect manufacturers, producers, and importers of designated drugs that sell such drugs during certain statutory periods. The proposed regulations also would except such tax from semimonthly deposit requirements.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/10/02/2023-21586/excise-tax-on-designated-drugs-procedural-requirements)
- API: https://www.federalregister.gov/api/v1/documents/2023-21586

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
